08:00 , Dec 17, 2012 |  BC Week In Review  |  Clinical News

Merrimack preclinical data

In mouse models of breast cancer, tumor deposition of MM-DX-929 was significantly correlated with treatment response to MM-302 as measured by tumor volume changes on MRI over a 2-month period (p=0.0004). Additionally, MM-DX-929 accumulation in...